Une seule dose peropératoire de ketorolac original pour prévenir les récidives de cancer: Serait-ce trop simple?

Translated title of the contribution: A single intraoperative dose of original ketorolac to prevent cancer recurrence: Is that too simple?

P. Forget* (Corresponding Author), M. De Kock

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Perioperative tumor growth acceleration is associated with inflammatory pathway activation. Non-steroidal anti-inflammatory drugs, particularly ketorolac, are a promising way to improve patient outcome.
Original languageUndefined/Unknown
Pages (from-to)391-395
Number of pages5
JournalLouvain Medical
Volume133
Issue number6
Publication statusPublished - Jun 2014

    Fingerprint

Keywords

  • Ketorolac
  • postoperative cancer recurrence
  • Inflammation

Cite this